{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:47Z","timestamp":1793146607148,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Investigator Initiated Studies Program of Merck, Sharp & Dohme Corp.","award":["IISP 37180"],"award-info":[{"award-number":["IISP 37180"]}]},{"name":"2009 American Headache Society\/Migraine Research Foundation Thomas E. Heftler Migraine Research Award"},{"name":"NYUCD (New York University College of Dentistry)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.expneurol.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T13:39:08Z","timestamp":1431610748000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain"],"prefix":"10.1016","volume":"271","author":[{"given":"Marcela","family":"Romero-Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.05.005_bb0005","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1586\/14737175.2013.827472","article-title":"Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine","volume":"13","author":"Akerman","year":"2013","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0010","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.22292","article-title":"Evidence for a vascular factor in migraine","volume":"69","author":"Asghar","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0015","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnins.2014.00023","article-title":"Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis","volume":"8","author":"Assas","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0020","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1016\/j.bmcl.2012.04.105","article-title":"MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats","volume":"22","author":"Bell","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0025","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","article-title":"CGRP receptors in the control of pain and inflammation","volume":"9","author":"Benemei","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0030","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0006-8993(91)90024-P","article-title":"Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo","volume":"559","author":"Biella","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0035","doi-asserted-by":"publisher","first-page":"C19","DOI":"10.1007\/BF01991124","article-title":"The contribution of calcitonin gene-related peptide (CGRP) to neurogenic vasodilator responses","volume":"38","author":"Brain","year":"1993","journal-title":"Agents Actions"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0040","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1744-8069-7-94","article-title":"Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization","volume":"7","author":"Cady","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21897","article-title":"Triptan-induced latent sensitization: a possible basis for medication overuse headache","volume":"67","author":"De Felice","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0050","first-page":"647967","article-title":"Repeated muscle injury as a presumptive trigger for chronic masticatory muscle pain","volume":"2011","author":"Dessem","year":"2011","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0055","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0333102410388435","article-title":"BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study","volume":"31","author":"Diener","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0060","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.neuroscience.2008.01.006","article-title":"Role of interleukin-6 in chronic muscle hyperalgesic priming","volume":"152","author":"Dina","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0065","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0070","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","article-title":"Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0080","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jebdp.2011.06.002","article-title":"Temporomandibular disorder (TMD) pain-related disability found related to depression, nonspecific physical symptoms, and pain duration at 3 international sites","volume":"11","author":"Dworkin","year":"2011","journal-title":"J. Evid. Based Dent. Pract."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0075","doi-asserted-by":"publisher","first-page":"273","DOI":"10.14219\/jada.archive.1990.0043","article-title":"Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls","volume":"120","author":"Dworkin","year":"1990","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0085","series-title":"Discovering Statistics Using SPSS","author":"Field","year":"2009"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0090","first-page":"287","article-title":"Migraine is the most prevalent primary headache in individuals with temporomandibular disorders","volume":"24","author":"Franco","year":"2011","journal-title":"J. Orofac. Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0095","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0100","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0105","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1526-4610.2009.01511.x","article-title":"Headache and symptoms of temporomandibular disorder: an epidemiological study","volume":"50","author":"Goncalves","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0115","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/AJP.0b013e31820e12f5","article-title":"Temporomandibular disorders are differentially associated with headache diagnoses: a controlled study","volume":"27","author":"Goncalves","year":"2011","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0110","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11916-012-0268-9","article-title":"How to investigate and treat: migraine in patients with temporomandibular disorders","volume":"16","author":"Gon\u00e7alves","year":"2012","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0120","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/cne.903150210","article-title":"Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat","volume":"315","author":"Hammond","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0125","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/01.WNL.0000286940.29755.61","article-title":"Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine","volume":"70","author":"Ho","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0130","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/cne.10836","article-title":"Differential rostral projections of caudal brainstem neurons receiving trigeminal input after masseter inflammation","volume":"465","author":"Ikeda","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0135","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0006-8993(99)01913-7","article-title":"Masseteric inflammation-induced Fos protein expression in the trigeminal interpolaris\/caudalis transition zone: contribution of somatosensory\u2013vagal\u2013adrenal integration","volume":"845","author":"Imbe","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0140","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000047887","article-title":"Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain","volume":"169","author":"Imbe","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0145","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0304-3959(99)00282-1","article-title":"A new animal model for assessing mechanisms and management of muscle hyperalgesia","volume":"85","author":"Kehl","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0150","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1155\/2005\/860354","article-title":"Neural mechanisms of temporomandibular joint and masticatory muscle pain: a possible role for peripheral glutamate receptor mechanisms","volume":"10","author":"Lam","year":"2005","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0155","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0160","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2010.08.032","article-title":"Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity","volume":"1358","author":"Lian","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0165","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1179\/crn.2009.029","article-title":"The prevalence of clinical diagnostic groups in patients with temporomandibular disorders","volume":"27","author":"Machado","year":"2009","journal-title":"Cranio"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0170","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pain.2010.07.018","article-title":"Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice","volume":"151","author":"Manjavachi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0175","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987","article-title":"Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain","volume":"7","author":"Markowitz","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0180","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.14219\/jada.archive.2006.0385","article-title":"Headache impact in patients with orofacial pain","volume":"137","author":"Mitrirattanakul","year":"2006","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0185","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00177756","article-title":"Substance P and calcitonin gene-related peptide: immunohistochemical localisation and microvascular effects in rabbit skeletal muscle","volume":"336","author":"Ohlen","year":"1987","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0190","series-title":"Bell's Oral and Facial Pain","author":"Okeson","year":"2014"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0195","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0006-8993(87)90074-6","article-title":"Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats","volume":"403","author":"Oku","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0200","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0205","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3758\/BF03200814","article-title":"EthoLog 2.2: a tool for the transcription and timing of behavior observation sessions","volume":"32","author":"Ottoni","year":"2000","journal-title":"Behav. Res. Methods Instrum. Comput."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0215","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2003"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0220","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1124\/mi.5.5.10","article-title":"Neurogenic inflammation and migraine: implications for the therapeutics","volume":"5","author":"Peroutka","year":"2005","journal-title":"Mol. Interv."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0225","doi-asserted-by":"publisher","first-page":"14881","DOI":"10.1073\/pnas.1005754107","article-title":"Compensation in the neural circuitry of fear conditioning awakens learning circuits in the bed nuclei of the stria terminalis","volume":"107","author":"Poulos","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0230","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0304-3959(03)00093-9","article-title":"Innocuous jaw movements increase c-fos expression in trigeminal sensory nuclei produced by masseter muscle inflammation","volume":"104","author":"Ro","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0240","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/JPR.S37593","article-title":"Orofacial pain management: current perspectives","volume":"7","author":"Romero-Reyes","year":"2014","journal-title":"J. Pain Res."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0235","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1526-4610.2012.02226.x","article-title":"Spontaneous behavioral responses in the orofacial region: a model of trigeminal pain in mouse","volume":"53","author":"Romero-Reyes","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0245","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/jpet.109.163816","article-title":"Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist","volume":"333","author":"Salvatore","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0250","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0304-3959(90)91095-Z","article-title":"Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord","volume":"42","author":"Smullin","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0255","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/cne.20797","article-title":"Trigeminal transition zone\/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats","volume":"493","author":"Sugiyo","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0260","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3959(03)00008-3","article-title":"The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin","volume":"104","author":"Sun","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2015.05.005_bb0265","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1152\/jn.00339.2004","article-title":"Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization","volume":"92","author":"Sun","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0270","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1096-9861(19990920)412:2<276::AID-CNE7>3.0.CO;2-9","article-title":"Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain","volume":"412","author":"Zhou","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2015.05.005_bb0275","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:58:12Z","timestamp":1717876692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":54,"alternative-id":["S0014488615001521"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725504633.793520523","asserted-by":"object"}]},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}